Ernexa Therapeutics Inc. (ERNA, ERNAW)

CIK 748592 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Ernexa Therapeutics Inc..

Recent SEC filings

FiledFormAccession number
Nov 6, 202610-Q0001493152-26-050501
Oct 30, 2026SCHEDULE 13G/A0001193125-26-441302
Oct 15, 20268-K0001493152-26-047287
Sep 22, 202630001493152-26-043714
Sep 16, 20268-K0001493152-26-042934
Sep 16, 20268-K0001493152-26-042963
Sep 1, 202640001493152-26-041137
Sep 1, 202640001493152-26-041132
Sep 1, 202640001493152-26-041130
Sep 1, 202640001493152-26-041133
Sep 1, 202640001493152-26-041135
Sep 1, 202640001493152-26-041131
Aug 27, 202630001493152-26-040466
Aug 6, 202610-Q0001493152-26-036424
Jul 2, 20268-K0001493152-26-031920
Jul 2, 20268-K0001493152-26-031930
Jun 26, 20268-K0001493152-26-030306
May 20, 2026SCHEDULE 13G/A0001708828-26-000225
May 15, 2026SCHEDULE 13G/A0001193125-26-227556
May 15, 2026SCHEDULE 13G/A0001193125-26-227548
May 14, 2026SCHEDULE 13G0001171520-26-000096
May 14, 2026SCHEDULE 13G0001708828-26-000185
May 13, 2026SCHEDULE 13G/A0001104659-26-060524
May 11, 2026ARS0001493152-26-022288
May 11, 202610-Q0001493152-26-022276